Structural Basis of Response Regulator Dephosphorylation by Rap Phosphatases by Parashar, Vijay et al.
Structural Basis of Response Regulator
Dephosphorylation by Rap Phosphatases
Vijay Parashar
1, Nicolas Mirouze
2, David A. Dubnau
1,2, Matthew B. Neiditch
1*
1Department of Microbiology and Molecular Genetics, UMDNJ–New Jersey Medical School, Newark, New Jersey, United States of America, 2Public Health Research
Institute Center, UMDNJ–New Jersey Medical School, Newark, New Jersey, United States of America
Abstract
Bacterial Rap family proteins have been most extensively studied in Bacillus subtilis, where they regulate activities including
sporulation, genetic competence, antibiotic expression, and the movement of the ICEBs1 transposon. One subset of Rap
proteins consists of phosphatases that control B. subtilis and B. anthracis sporulation by dephosphorylating the response
regulator Spo0F. The mechanistic basis of Rap phosphatase activity was unknown. Here we present the RapH-Spo0F X-ray
crystal structure, which shows that Rap proteins consist of a 3-helix bundle and a tetratricopeptide repeat domain. Extensive
biochemical and genetic functional studies reveal the importance of the observed RapH-Spo0F interactions, including the
catalytic role of a glutamine in the RapH 3-helix bundle that inserts into the Spo0F active site. We show that in addition to
dephosphorylating Spo0F, RapH can antagonize sporulation by sterically blocking phosphoryl transfer to and from Spo0F.
Our structure-function analysis of the RapH-Spo0F interaction identified Rap protein residues critical for Spo0F phosphatase
activity. This information enabled us to assign Spo0F phosphatase activity to a Rap protein based on sequence alone, which
was not previously possible. Finally, as the ultimate test of our newfound understanding of the structural requirements for
Rap phosphatase function, a non-phosphatase Rap protein that inhibits the binding of the response regulator ComA to
DNA was rationally engineered to dephosphorylate Spo0F. In addition to revealing the mechanistic basis of response
regulator dephosphorylation by Rap proteins, our studies support the previously proposed T-loop-Y allostery model of
receiver domain regulation that restricts the aromatic ‘‘switch’’ residue to an internal position when the b4-a4 loop adopts
an active-site proximal conformation.
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Introduction
B. subtilis spore development is regulated by a phosphorelay
signal transduction pathway that is the prototype for all
phosphorelay signal transduction pathways in bacteria (Figure 1;
[1]). The B. subtilis sporulation signal transduction pathway is
initiated by five histidine kinases—KinA, KinB, KinC, KinD, and
KinE—that autophosphorylate in response to unknown environ-
mental and physiological cues coincident with nutritional
starvation (Figure 1, left panel; [2]). Signaling converges on the
centrally important intermediate response regulator Spo0F, which
autophosphorylates using phosphohistidines in a sporulation
histidine kinase as a phosphoryl donor. Spo0F then phosphorylates
the histidine phosphotransfer (HPt) protein Spo0B, which in the
final pathway step relays phosphoryl groups to Spo0A. Phosphor-
ylated Spo0A then directly activates or represses 121 genes
comprising the Spo0A regulon [3]. In total, however, at least 520
B. subtilis genes are significantly upregulated or downregulated as a
result of Spo0A phosphorylation [4].
Phosphorelay pathway intermediate response regulator proteins
like Spo0F, which consist entirely of a single receiver (REC) domain
identical in structure to the N-terminal REC domains of transcription
factor response regulators, dephosphorylate by transferring their
phosphoryl groups to water in autohydrolysis reactions (Figure 1,
right panel; [5,6]). The dephosphorylation of intermediate response
regulators causes the direction of phosphoryl flow to reverse(Figure 1,
right panel). That is, the intermediate response regulator pulls
phosphoryl groups from the HPt, which in turn dephosphorylates the
downstream response regulator. The rate of response regulator
dephosphorylation is determined by autohydrolysis activity intrinsic
to the REC domain and the activity of response regulator-specific
phosphatases, such as Rap proteins (Figure 1, right panel; [7,8]).
Rap proteins, named after the founding members of the family,
which were shown to be response regulator aspartate phosphatases,
have been most thoroughly studied in B. subtilis, where they are
central to the regulation of diverse developmental processes
including sporulation and genetic competence [8,9]. In B. subtilis
alone there are 11 homologous Rap proteins encoded on the
chromosome, and there are at least four additional Rap proteins
encoded on B. subtilis plasmids [10,11].
A subset of Rap proteins, consisting of RapA, RapB, RapE, and
RapH, dephosphorylates Spo0F, consequently reducing the level
of phosphorylated Spo0A in the cell and inhibiting sporulation
(Figure 1, right panel; [8,12,13]).
We have determined the X-ray crystal structure of a Rap
phosphatase, RapH, in complex with its target protein, Spo0F,
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2+, an important constituent of the Spo0F
active site. The RapH-Spo0F crystallographic asymmetric unit
contains RapH-Spo0F complexes in two different conformations,
reflecting different steps along the Spo0F dephosphorylation
pathway. To our knowledge, the RapH-Spo0F X-ray crystal
structure represents the first structure of a Rap protein or a Rap
protein in complex with its substrate. As expected from their
amino acid sequences, Rap proteins have an overall structure that
is radically different from the known structures of other bacterial
phosphatases. The RapH-Spo0F crystal structure, along with in
vitro biochemical and in vivo genetic data, provides mechanistic
insight into Rap protein function, specifically the molecular basis
of Rap phosphatase activity.
Results
Overall RapH-Spo0F Crystal Structure
To determine the mechanistic basis of Rap phosphatase activity,
we crystallized B. subtilis RapH in complex with its target response
regulator Spo0F. The single wavelength anomalous diffraction
method was used to obtain experimental phases and the RapH-
Spo0F structure was ultimately refined to 2.20 A ˚ resolution (Table
S1). RapH forms dimers in the RapH-Spo0F crystals; this is
consistent with gel filtration studies showing that RapH forms stable
dimers in solution (Figures 2A, 2B, and S1A). Each RapH protomer
in the RapH2 dimer is bound to a monomer of Spo0F, forming a
(RapH-Spo0F)2 complex, and each Spo0F monomer coordinates a
magnesium ion in its active site, consistent with the fact that
magnesium was included in the protein purification, crystallization,
and cryoprotection buffers (Figures 2A, 3A, and 3B).
As discussed in detail below, within single RapH-Spo0F crystals
there are two RapH-Spo0F complexes in different conformations
(Figures 2A, 2B, and S1A). To discuss the RapH-Spo0F structure,
we have adopted the following nomenclature. The different
RapH-Spo0F complexes in the crystallographic asymmetric unit
are named RapHA-Spo0FA and RapHB-Spo0FB (Figures 2A and
S1A). RapHA dimerizes around a crystallographic 2-fold symme-
try axis forming a (RapHA-Spo0FA)2 complex (Figure 2A). This
complex is a heterotetramer comprised of RapHA, RapHA9,
Spo0FA, and Spo0FA9, and it buries 4,127 A ˚ 2 of surface area at the
large RapHA-RapHA9 interface. Similarly, RapHB dimerizes
around a crystallographic 2-fold symmetry axis forming (RapHB-
Spo0FB)2 (Figure S1A). This heterotetramer is composed of
RapHB, RapHB9, Spo0FB, and Spo0FB9, and it buries 4,187 A ˚ 2
surface area at the RapHB-RapHB9 interface. Where subscripts
and superscripts are omitted from the protein names below, we
refer to both of the non-identical copies of RapH or Spo0F in the
crystallographic asymmetric unit.
RapH Structure
The RapH-Spo0F X-ray crystal structure shows that RapHA
contains an N-terminal 3-helix bundle (a1-a3) (Figure 2A and 2C).
RapHB also appears to form an N-terminal 3-helix bundle, but in
contrast to Spo0FA the electron density corresponding to residues
27–42 of helix a2 and 43–45 of the a2-a3 loop were not clearly
interpretable and these residues were not modeled (Figures S2,
S1A, and S1B). Buried at the core of the RapH 3-helix bundle is
tryptophan-17. Without exception, Rap proteins have tryptophan
at this position, and an N-terminal 3-helix bundle is probably a
universal feature of Rap proteins (Figure 4). The RapH-Spo0F
structure suggests that the conserved tryptophan is important for
the folding of the Rap protein N-terminal 3-helix bundle, and as
discussed in detail below the Rap protein 3-helix bundle is
centrally important for phosphatase function.
Connected to the C-terminus of the RapH 3-helix bundle via a
flexible linker and a short helix (a4) is a large right-handed
superhelical domain composed of seven pairs of antiparallel a-
helices (Figures 2C and S1B). Each pair of antiparallel a-helices is
a helix-turn-helix consisting of an N-terminal helix (helix A), a
connecting loop, and a C-terminal helix (helix B) (Figure 4). The
antiparallel a-helices comprising pairs 1–5 and pair 7 contain
tetratricopeptide repeat (TPR) sequences which are 34 amino acid
motifs frequently found in tandem (Figure 4). A pair of antiparallel
a-helices (a15–a16) separating TPR5 and TPR6 resembles a TPR
helix-turn-helix fold in its overall structure but does not encode the
TPR motif signature residues [14]. Additionally, the loop (residues
289–296) connecting TPR5 helix B to helix a15 is longer than the
other TPR fold-connecting loops, and residues 292–294 are
disordered in RapHB (Figures 4 and S1B). Because the RapH C-
terminal domain consists of six bona fide TPR folds and a helix-
turn-helix fold that largely resembles a TPR fold and contributes
like a TPR fold to the C-terminal domain superhelix, we refer to
the entire region (amino acids 77–376) as the TPR domain.
Overall, RapHA and RapHB have very similar tertiary structures
and align with a root mean-square deviation of 0.9 A ˚ for 332 Ca
atoms modeled in both structures; however, there are very
important conformational differences between them (see Figure
S2). We attribute these differences largely to the distinct crystal
packing environments of the RapHA and RapHB 3-helix bundles
and a4 helices. For example, the RapHA 3-helix bundle and helix
a4 interact with the RapHB TPR domain, burying 1,146.2 A ˚ 2
surface area (unpublished data). In contrast, residues in the RapHB
3-helix bundle make far fewer crystallographic contacts, burying
only 191.2 A ˚ 2 surface area. These differences may also explain why
residues 27–42 of helix a2, 43–45 of the a2-a3 loop, and 77–85 of
theregioncontainingtheconnectinghelixa4areorderedinRapHA
Author Summary
A phosphorelay signal transduction pathway regulates
sporulation in numerous Bacillus species including the
genetic model organism, B. subtilis, and the causative
agent of anthrax, B. anthracis. Histidine kinases initiate the
flow of phosphoryl groups along the phosphorelay
pathway, which then shuttles them to a downstream
response-regulator transcription factor called Spo0A.
Ultimately, sporulation is governed by the cellular con-
centration of phosphorylated Spo0A. In numerous Bacillus
species, Rap phosphatases function in opposition to the
histidine kinases, inhibiting Spo0A activation by dephos-
phorylating an intermediate pathway protein called Spo0F.
Here we present the structure of a Rap protein, RapH, in
complex with Spo0F, as determined by X-ray crystallogra-
phy. The RapH–Spo0F structure, along with biochemical
and genetic studies, reveals the mechanism of Rap-
protein-mediated Spo0F dephosphorylation. We used
information gleaned from our structure–function analysis,
first, to assign Spo0F phosphatase activity to an unchar-
acterized Rap protein, RapJ, on the basis of sequence
alone, and, second, to engineer Spo0F phosphatase
activity de novo into a non-phosphatase Rap protein,
RapF. We found that in addition to dephosphorylating
Spo0F, Rap proteins can inhibit the sporulation phosphor-
elay by sterically blocking the transfer of phosphoryl
groups to and from Spo0F. Ultimately, new classes of
drugs might be developed that disrupt the flow of
phosphoryl groups along phosphotransfer signaling path-
ways by mimicking the antagonistic effects of Rap proteins
on response regulators.
Rap Phosphatase Structure and Function
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with the conformational differences observed in RapHA and
RapHB, Spo0FA and Spo0FB are in different conformations.
Spo0F Conformational Changes Caused by RapH
Divalent metal ions were previously shown to be required for
both Rap-mediated Spo0F dephosphorylation as well as Spo0F
autodephosphorylation [15,16]. Consistent with these observa-
tions, both Spo0FA and Spo0FB are bound to Mg
2+ (Figure 3B).
Alignment of Spo0FA with the previously determined crystal
structure of Spo0F bound to Mn
2+ (PDB ID 1PEY) revealed that
RapHA induces conformational changes in Spo0FA (Figure 3A,
right panel; [17]).
More specifically, this alignment showed that RapHA binding
causes the entire Spo0FA b4-a4 loop to dramatically shift and flip
toward the active site (Figure 3A, right panel). This conformational
change is exemplified by Tyr84, positioned in the middle of the
Spo0FA b4-a4 loop, which experiences 2.1–5.0 A ˚ displacements in
its main-chain atoms and 5.4–10.3 A ˚ shifts in its side-chain atoms
(see Figure 3A, right panel). As described in detail below, the
interaction of Spo0FA Tyr84 with a conserved binding cleft in
RapHA, formed by RapHA residues Glu45, Asp46, and Leu50,
appears to be critically important for RapH-mediated dephos-
phorylation of Spo0F, and alanine substituted for Tyr84 was
previously shown to render Spo0F resistant to the phosphatase
activity of the RapH homolog RapB [16].
RapHA causes the Spo0FA switch residue Thr82, located at the
C-terminal end of strand b4, to translate approximately 1 A ˚ and
its sidechain to rotate more than 120 degrees towards the Spo0FA
active site (Figure 3A, right panel). The rotation of a conserved
threonine or serine at this position in response regulators enables
its sidechain hydroxyl oxygen to hydrogen bond with a phosphoryl
group oxygen in the active-site phosphoaspartate [18,19]. The
RapHA-induced conformational change in Spo0FA Thr82 is
accompanied by the rotation of the Spo0FA His101 sidechain to
an internalized position where it enters space vacated by Thr82
(Figure 3A, right panel). It is important to note that while Spo0F is
not phosphorylated in the RapH-Spo0F structure, RapHA locks
non-phosphorylated Spo0FA in the conformation corresponding to
a phosphorylation-stabilized receiver domain, which is character-
ized by the rotation of both switch residues, as described above,
and the movement of the b4-a4 loop towards the active site [20].
Finally, structural alignment of the RapH bound structures of
Spo0FA and Spo0FB revealed that they are in different conforma-
tions (Figure 3B). The entire b4-a4 loop, all of helix a4, and a
portionofthea4-b5looparedisorderedinSpo0FBasevidencedbya
lackofinterpretableelectrondensitycorrespondingto these residues.
This disorder, particularly in the b4-a4 loop, which, as described
below, makes important regulatory contacts with RapH in the
RapHA-Spo0FA structure, implies that RapHB and Spo0FB may be
more loosely associated than RapHA and Spo0FA. Consistent with
this hypothesis, the Spo0FB switch residues are in the non-
Figure 1. Rap proteins and Phr peptides regulate B. subtilis sporulation signal transduction. The B. subtilis sporulation kinases (KinA-E) are
depicted as membranous proteins for the sake of simplicity; however, KinA and KinE are actually soluble cytoplasmic receptors. Phosphoryl groups
are transferred to Spo0F, Spo0B, and ultimately to Spo0A. When the level of Spo0A,P reaches a critical level, sporulation is triggered (left panel). Rap
proteins dephosphorylate Spo0F,P causing phosphoryl groups to flow away from Spo0A, inhibiting sporulation (right panel). The Spo0K permease
(not pictured) imports Phr peptides into the cytoplasm where they positively regulate sporulation by binding to Rap proteins and inhibiting Spo0F
dephosphorylation. The Spo0E family member phosphatases, Spo0E, YisI, and YnzD, dephosphorylate B. subtilis Spo0A [48,49]. REC, Receiver Domain;
H, histidine; D, aspartic acid; P, phosphoryl group; Pi, inorganic phosphate.
doi:10.1371/journal.pbio.1000589.g001
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PLoS Biology | www.plosbiology.org 3 February 2011 | Volume 9 | Issue 2 | e1000589phosphorylated conformation. That is, the sidechain of Thr82 is
pointing away from the active site, and the His101 side chain is in an
external conformation (Figure 3B). Because the Spo0FB b4-a4l o o p
is disordered and could not be modeled, its conformation could not
be directly compared to that of the Spo0FA b4-a4l o o p .
Functional Analysis of the RapH-Spo0F Interface In Vitro
To determine the mechanism of RapH phosphatase activity, we
systematically explored the functional significance of the RapH-
Spo0F interactions observed in the RapH-Spo0F X-ray crystal
structure. The phosphatase activity of RapH mutants containing
single mutations distributed throughout the RapH-Spo0F interface
was first tested in vitro using a biochemical phosphatase assay.
Using the in vitro phosphatase assay, we compared the rate of
Spo0F dephosphorylation catalyzed by mutant RapH proteins to
that of wild-type RapH and no RapH (Spo0F,P autodepho-
sphorylation) controls (Figure 5).
The RapH N-terminal 3-helix bundle and C-terminal TPR
domain interact with Spo0F; therefore, interfacial residues in both
of these domains were targeted for mutagenesis (Figure 5A and 5C).
The interaction of the RapHA 3-helix bundle domain and Spo0FA
buries a total of 968 A ˚ 2 surface area, and the vast majority of
RapHA 3-helix bundle residues buried in the RapHA-Spo0FA
interface are located in RapHA helix a3 and the a2-a3 loop
(Figure 5A). The RapH 3-helix bundle contacts residues in Spo0FA
helices a1, a2, and a5, and in the b1-a1, b2-a2, b3-a3, b4-a4, and
b5-a5 loops, which surround the Spo0FA active-site pocket
(Figures 5A and S3). Initially, we generated RapH proteins
containing individual alanine substitutions targeting the following
3-helix bundle residues that we identified as being buried in the
Spo0F interface: Glu45, Gln47, Leu50, Leu55, and Phe58
(Figure 5A). Purified RapH-L50A, RapH-L55A, and RapH-F58A
were as soluble as wild-type RapH; however, RapH-E45A and
RapH-Q47A were largely insoluble. RapH-E45A was not studied
Figure 2. RapH-Spo0F structure. (A) The (RapHA-Spo0FA)2 heterotetramer comprised of RapHA (blue), Spo0FA (brown), RapHA’ (green), and
Spo0FA’ (magenta). (B) Size exclusion chromatography shows that RapH (MWtheor 44.1 kDa) forms RapH2 dimers (MWexper 85.1 kDa) in solution. The
peak positions of gel filtration standards are indicted by vertical lines above the absorbance trace. (C) To obtain this view of RapHA, the structure
illustrated in panel A was rotated 90u in the direction indicated by the arrow. The RapHA N-terminal 3-helix bundle (light blue) is connected to the C-
terminal TPR domain by a flexible linker (dashed lines) and a short helix (black cylinder). HTH, helix-turn-helix.
doi:10.1371/journal.pbio.1000589.g002
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PLoS Biology | www.plosbiology.org 4 February 2011 | Volume 9 | Issue 2 | e1000589Figure 3. Spo0F structural alignments. (A, left panel) RapHA (blue surface) in complex with Spo0FA-Mg
2+ (yellow cartoon). (A, right panel)
Expanded view of the area enclosed by the black rectangle in the left panel showing the structural alignment of Spo0FA-Mg
2+ (grey ribbon with
yellow sticks) and Spo0F-Mn
2+ (grey ribbon with magenta sticks, PDB ID 1PEY). Mg
2+ and Mn
2+ are depicted as green and orange spheres,
respectively. This alignment reveals that RapHA causes Spo0F Thr82 to rotate towards the active site, Spo0F His101 to adopt an internalized
conformation, and the Spo0F b4-a4 loop to shift towards the active site as indicated by the white curved arrows. Spo0F Lys104 could hydrogen bond
with a phosphoryl group oxygen in the active-site phosphoaspartate (see Figure 9C). The pseudodihedral angle created by the Ca atoms equivalent
to the Spo0F Ca atoms in residues 82, 83, 84, and 85 was previously used to quantify conformational changes in the FixJ and CheY receiver domain
b4-a4 loops [34,50,51]. A rotation of 51u around this pseudodihedral angle is observed in the RapHA-Spo0FA structure. The side chain of Spo0FA Lys56
Rap Phosphatase Structure and Function
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However, additional effort to obtain highly soluble RapH protein
containing an amino acid substitution at Gln47 was warranted
because RapH Gln47 inserts into the Spo0F active-site pocket, and
we hypothesized that Gln47 plays a particularly important role in
RapH function. Therefore, we generated RapH-Q47N and RapH-
Q47E which were as soluble as wild-type RapH.
Our biochemical analysis showed that RapH-L50A and RapH-
F58A displayed reduced phosphatase activity compared to wild-
type RapH (Figure 5B). For example, after 30 min 26% of
Spo0F,P remained in the RapH-L50A reaction, while only 13%
remained in the wild-type control (Figure 5B). Similarly, after
30 min 28% of Spo0F,P remained in the RapH-F58A reaction,
while only 3% remained in its wild-type RapH control (Figure 5B).
While RapH-L55A displayed a wild-type phenotype, one mutant,
RapH-Q47N, had an even greater phosphatase defect than the
RapH-L50A and RapH-F58A mutants (Figure 5B). In fact, RapH-
Q47N appears to be catalytically dead. That is, the RapH-Q47N
reaction is nearly indistinguishable from the no RapH control.
It is important to note that the mutation of RapH Gln47 to
asparagine is rather conservative; glutamine and asparagine are
uncharged and differ by the presence or absence of a single side-
chain carbon atom, respectively. However, shortening the sidechain
of RapH Gln47 by the length of one carbon-carbon bond (,1.5 A ˚)
was sufficient to completely eliminate RapH phosphatase activity in
vitro(Figure5B).Importantly,theRapH-Q47Emutantthatreplaces
glutamine-47 with glutamate displays wild-type phosphatase activity
(Figure 5B). As discussed in detail below, we hypothesize that the
RapH Gln47 side chain orients a water molecule for nucleophilic
attack on the Spo0F aspartylphosphate phosphorous atom. Since
RapH-Q47E displays wild-type activity, it appears that an 2O
2
group can substitute functionally for the 2NH2 group in the Gln47
side chain to coordinate the attacking water.
In addition to interacting with the RapH 3-helix bundle, Spo0F
interacts extensively with the RapH TPR domain, burying 968 A ˚ 2
surface area in RapHA-Spo0FA and 953 A ˚ 2 surface area in
RapHB-Spo0FB (Figure 5C). While it is possible that Spo0F
interactions with the RapH 3-helix bundle are sufficient for RapH
phosphatase activity, we hypothesized that the RapH TPR
domain contributes important regulatory contacts to the RapH-
Spo0F interface as well. To begin to test this hypothesis, we
generated RapH-D134A, RapH-E137A, and RapH-Y175A and
measured the phosphatase activity of these mutants in vitro
(Figure 5D). RapH-D134A, RapH-E137A, and RapH-Y175A
were significantly impaired for phosphatase function (Figure 5D).
After 30 min 13% and 54% of Spo0F,P remained in the RapH-
D134A and RapH-Y175A reactions, respectively, while only 3%
remained in their wild-type control (Figure 5D). Similarly, after
40 min 15% of Spo0F,P remained in the RapH-E137A reaction
while only 7% remained in its wild-type control. Therefore, we
conclude that Spo0F interactions with both the RapH N-terminal
3-helix bundle and the C-terminal TPR domain are required for
wild-type phosphatase activity in vitro.
Functional Analysis of the RapH-Spo0F Interface In Vivo
To confirm the physiological relevance of our X-ray crystallo-
graphic and biochemical results, we measured wild-type and
mutant RapH protein activity in B. subtilis as a function of Spo0A
activation using a luciferase reporter gene under the control of the
Spo0A-driven promoter PspoIIG (Figure 6). Since RapH dephos-
phorylates Spo0F, resulting in the repression of Spo0A transcrip-
tional activity, overexpression of wild-type RapH inhibits the
expression of the PspoIIG-driven luciferase reporter (Figure 6A and
6B). Conversely, less active RapH mutants will display elevated
levels of luciferase expression from the PspoIIG reporter.
We first tested the effects of the RapH mutants described above
on Spo0F dephosphorylation in B. subtilis. RapH-L55A, which
displays wild-type activity in vitro, showed reduced activity in vivo;
however, this appears to be the result of its significantly reduced
expression compared to wild-type RapH (Figures 6A and S4). In
close agreement with our biochemical studies, RapH-Q47N,
RapH-L50A, and RapH-F58A displayed reduced activity in vivo
(Figure 6A). Western blotting confirmed that all of these RapH
mutants were produced at levels comparable to wild-type RapH in
B. subtilis (Figure S4).
To further extend our analysis of the RapH-Spo0F interaction
surface and to identify additional regulatory contacts, we
examined a number of additional RapH proteins containing 3-
helix bundle mutations lying in the Spo0F interface (Figures 5A,
6A, and S4). While RapH-I51A displayed wild-type RapH
function, RapH-E45A and RapH-D46A displayed drastically
reduced activity in vivo (Figure 6A). Thus, the RapHA-Spo0FA
complex shows that RapH residues Glu45, Asp46, and Leu50
surround the side chain of Spo0F Tyr84, and our functional
analysis shows that mutating any of these RapH residues to
alanine inhibits RapH activity (Figures 5A, 5B, and 6A). It is also
important to note that the identity of the Spo0FA Tyr84 binding
pocket residues is highly conserved in all Rap proteins known to
dephosphorylate Spo0F and that both RapH Glu45 and the
Spo0F Tyr84-containing b4-a4 loop are disordered in RapHB-
Spo0FB (Figures 3B and 4). Thus, the observed interaction of
RapH with Tyr84 appears to be important for locking Spo0F in
the conformation observed in RapHA-Spo0FA and required for
wild-type levels of RapH activity in vivo and in vitro.
In agreement with our biochemical results, RapH proteins
containing mutations in residues lining the surface of the RapH
TPR domain-Spo0F interface—L96A, D134A, E137A, and
Y175A—displayed reduced activity in B. subtilis (Figures 5C,
6B, and S4). These results were not surprising because RapH
residue Leu96, like Asp134 and Glu137, contributes to the
formation of the Spo0F Tyr13 binding pocket, and Spo0F Tyr13
was previously shown to be important for Rap protein-mediated
dephosphorylation of Spo0F (Figure 5C; [16]). Furthermore, the
RapH-Spo0F crystal structure shows that RapH residue Tyr175
hydrogen bonds to the Spo0F Mg
2+-coordinating residue Asp11
and may help stabilize Mg
2+ coordination, which is required for
dephosphorylation (Figure 5C; [15]). To complete our mutagenic
analysis of the RapH-Spo0F interface, we also tested RapH-
Q90A, which displayed wild-type activity in vivo (Figure 6B).
RapH Gln90 is located in the loop connecting helix a4 to TPR1
and lies on the periphery of the RapH-Spo0F interface (Figure 5C).
Including this mutation in our in vivo analysis resulted in complete
mutational coverage of the RapH-Spo0F interface. Ultimately, we
tested the effects of at least one mutation located in every RapH
is disordered, thus avoiding a clash with the repositioned b4-a4 loop. (B) A stereoview depicting the structural alignment of Spo0FA (yellow) and
Spo0FB (magenta) shows that Spo0FA adopts a ‘‘phosphorylated’’ conformation and Spo0FB adopts a ‘‘non-phosphorylated’’ conformation. The
Spo0FB b4-a4 loop, helix a4, and a portion of the a4-b5 loop are disordered. The Mg
2+ ion coordinated by Spo0FA Asp11, Asp54, and Lys56 is
depicted by a green sphere. The Mg
2+ ion coordinated by Spo0FB Asp11, Asp54, and Lys56 is depicted by an orange sphere. Structural alignments
were performed with DaliLite [45].
doi:10.1371/journal.pbio.1000589.g003
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vivo and in vitro functional analysis are summarized in Figure 4.
RapH Obstructs Phosphotransfer to and from Spo0F
Taken together, our X-ray crystallographic, biochemical, and
genetic results suggest that the RapH-Spo0F interfaces we
identified in the RapH-Spo0F crystal structure are physiologically
important. However, we found it curious that RapH mutants
displaying a severe loss-of-function phenotype in vitro, such as
RapH-Q47N, which is catalytically dead, still inhibited, at least to
some degree, the flow of phosphoryl groups along the sporulation
phosphorelay in vivo (Figures 5B and 6A). Interestingly, the
RapH-Spo0F structure revealed that RapH binds to a Spo0F
surface containing numerous residues previously shown to be
important for its interaction with KinA and Spo0B (Figure S2;
[21]). Therefore, we hypothesized that catalytically dead RapH
mutants, and potentially wild-type RapH as well, could bind to
Spo0F and obstruct its phosphorylation by the sporulation
histidine kinases and phosphotransfer to Spo0B.
To test this hypothesis, we mixed Spo0F with the catalytically dead
RapH-Q47N mutant and found that it inhibited Spo0F phosphor-
ylation by KinA in a phosphotransfer assay when KinA, RapH-
Q47N, and Spo0F were present in a molar ratio of 0.006:0.4:1
(Figure 7). When the KinA:RapH-Q47N:Spo0F molar ratio was
0.006:4:1, phosphotransfer from KinA to Spo0F was nearly
undetectable even after 1 h (unpublished data). Not surprisingly,
RapH-Q47N also blocked phosphotransfer from Spo0F to Spo0B in
vitro (unpublished data). Furthermore, when we more drastically
disrupted the RapH-Spo0F interaction by incorporating another
RapH-Spo0F interface mutation, RapH-F58A, into the RapH-
Q 4 7 Nm u t a n t ,w ef o u n dt h a tt h ed o u b l em u t a t i o nr e l a x e dt h e
RapH-mediated inhibition of phosphotransfer from KinA to Spo0F
and from Spo0F to Spo0B (Figure 7 and unpublished data). Thus,
RapH-Q47N can bind Spo0F and restrict KinA and Spo0B access to
the Spo0F active site. Finally, while RapH residue Gln47 is absolutely
required for RapH to dephosphorylate Spo0F, our in vivo and in
vitro results suggest that this residue might not contribute significantly
to the RapH-Spo0F binding energy.
Sequence-Based Assignment of Rap Phosphatase Activity
In the absence of a Rap protein-Spo0F X-ray crystal structure,
sequence-based prediction of Rap protein function was not
previously possible. Mapping the sequence conservation of B.
subtilis RapA, RapB, RapE, and RapH, as well as B. anthracis Rap
proteins BXA0205 and BA3790, which have been shown to
dephosphorylate B. subtilis Spo0F, onto the structure of RapH
revealed 18 highly conserved positions in the RapH-Spo0F
interface (Figure 4; [22]). We hypothesized that these residues
occupy functionally important positions and that we could predict
whether other Rap proteins are Spo0F phosphatases based on
their amino acid sequence identity in these positions.
To test this hypothesis, we analyzed the sequence of other
Bacillus Rap proteins and determined that B. subtilis RapJ, among
other Rap proteins, contains a high degree of sequence similarity
in these interfacial residues (Figure 4). In fact, RapJ encodes a
residue that is identical to a residue in one of the other known
Spo0F Rap phosphatases in 15 of the 18 highly conserved
interfacial positions. The least well-conserved RapJ residues in the
18 highly conserved interfacial positions are Leu40, Asn46, and
Phe53, corresponding to RapH residues Ile40, Asp46, and Tyr53,
respectively (Figure 4). Modeling leucine in place of Ile40 in RapH
showed that leucine could substitute for its positional isomer
isoleucine without introducing atomic clashes (unpublished data).
Furthermore, the RapH-Spo0F structure showed that RapH
Asp46 makes only main-chain contacts with Spo0F, so it seemed
likely that a Rap phosphatase could tolerate asparagine in this
position. Finally, the hydroxyl moiety of RapH Tyr53 is not
involved in a hydrogen bond with Spo0F and its aromatic ring
appears to be more important to the Spo0F interaction; thus
Phe53 in RapJ would be unlikely to disrupt phosphatase function.
In contrast with RapJ, the non-phosphatase Rap protein RapD
conserves only 6 of the 18 highly conserved interfacial positions.
Modeling RapD residues in place of the conserved RapH
interfacial residues showed that many of them would clash with
Spo0F (unpublished data). For example, RapD contains trypto-
phan at residue 50 where RapH contains leucine. RapD also
encodes alanine at residue 58 where RapH contains phenylala-
nine, and alanine substituted for phenylalanine at this position in
RapH resulted in a loss of function in vitro and in vivo.
Furthermore, RapD contains threonine at the position equivalent
to the RapH catalytic residue Gln47.
To test our prediction that RapJ is a Spo0F phosphatase, we
overexpressed and purified RapJ and evaluated its ability to
dephosphorylate Spo0F in vitro. Indeed, RapJ dephosphorylated
Spo0F (Figure 8A). After 30 min only 4% of Spo0F,P remained
in the RapJ reaction, while 60% remained in the no RapJ control
(Figure 8A). This result is consistent with microarray data showing
that RapJ overproduction in B. subtilis affects the expression of 20
Spo0A-regulated operons [23]. Finally, like every other Rap
protein that we have tested to date, RapJ is dimeric as determined
by gel filtration chromatography (Figure 8B). Thus, insight
obtained from the RapH-Spo0F X-ray crystal structure, together
with biochemical and genetic analysis of the observed RapH-
Spo0F interactions, has enabled us to assign Rap phosphatase
function based on sequence alone.
Engineering De Novo Rap Phosphatase Activity
To rigorously test our understanding of the structural
requirements for Rap phosphatase activity and also to confirm
that we have identified the biologically important Rap-Spo0F
interface, we engineered a non-phosphatase Rap protein to
dephosphorylate Spo0F. Sequence alignment revealed that the
Figure 4. Rap phosphatase sequence alignment. The amino acid sequences of Bacillus Rap proteins previously demonstrated to
dephosphorylate Spo0F in vitro were aligned using the Blosum62 matrix in Geneious Pro (Biomatters Ltd.). The residue numbers indicated above the
sequences refer to RapH. The highly conserved tryptophan at the core of the N-terminal 3-helix bundle is colored green. The ConSurf server was used
to determine surface residue conservation [46]. The highly conserved residues in the RapH-Spo0F interface are surrounded by black boxes. Alanine
substitutions at the positions highlighted by red boxes resulted in the greatest loss of RapH function in vivo. Alanine substitutions at the positions
highlighted by blue or green boxes resulted in intermediate or no loss of RapH function in vivo, respectively. Asparagine substitution at RapH residue
Gln47, which is highlighted by a black box, resulted in an intermediate loss of RapH function in vivo. Alanine substitutions at the positions marked
with red arrowheads resulted in the greatest loss of RapH function in vitro. Alanine substitutions at the positions marked with blue or green
arrowheads resulted in intermediate or no loss of RapH function in vitro, respectively. Asparagine or glutamate substitution at RapH residue Gln47,
which is marked with a black arrowhead and in bold type, resulted in complete loss-of-function or no loss-of-function in vitro, respectively. RapH
secondary structure assignments were made using the PyMOL algorithm [41]. The secondary structure cylinder colors correspond to the coloring
scheme used in Figures 2C and S1B.
doi:10.1371/journal.pbio.1000589.g004
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domain of ComA and does not dephosphorylate its REC domain
[24,25], contains a glutamine at residue 47 which aligns with the
RapH catalytic residue Gln47. Additionally, RapF contains a
residue identical to at least one of the other Spo0F Rap
phosphatases in all of the highly conserved interfacial residues
with only two exceptions (Table S2). More specifically, RapF
contains histidine and lysine where RapH contains Leu50 and
Ser133, respectively.
We predicted that lysine could be tolerated in RapF at the
position corresponding to RapH Ser133 without disrupting
potential Spo0F phosphatase activity because (1) the RapHA
Ser133 side chain 2OH points away from the Spo0FA interface
and only the Cb side-chain atom and main-chain atoms are buried
in the Spo0FA interface, (2) in RapHB only main-chain atoms
belonging to Ser133 are buried in the Spo0FB interface, and (3)
modeling lysine at RapH residue 133 revealed that nearly every
lysine side-chain rotamer could be tolerated without clashing with
Spo0F. However, modeling histidine at RapH Leu50 in the
RapH-Spo0F structure showed that every histidine side-chain
rotamer clashed with Spo0F or RapH itself (unpublished data).
Based on these findings, we hypothesized that this one residue,
His50, disables Spo0F phosphatase function in RapF.
To test the above hypothesis, we purified RapF-H50L and
measured its phosphatase activity in vitro. Indeed, RapF-H50L
dephosphorylates Spo0F, while wild-type RapF does not. After
30 min only 16% of Spo0F,P remained in the RapF-H50L
reaction while 54% remained in the wild-type RapF control
(Figure 8C). These results, along with our structural analysis,
reveal the mechanistic basis underlying the inability of wild-type
RapF to dephosphorylate Spo0F and confirm that we have
identified the biologically important Rap protein surface and
many of the structural determinants required for Rap phosphatase
activity. Furthermore, this represents an interesting and rare
example of rational surface design that generates new target
protein specificity and de novo enzymatic function.
Discussion
Mechanism of Rap Activity
Our X-ray crystallographic, biochemical, and genetic studies
suggest that RapHA-Spo0FA represents a complex formed in B.
subtilis when RapH binds to phosphorylated Spo0F. Conversely,
RapHB-Spo0FB depicts a conformation adopted immediately
following RapH-mediated Spo0F dephosphorylation. The disorder
we observed in residues comprising the RapHB-Spo0FB interface
suggests that the RapHB-Spo0FB structure represents a destabilized
RapH-Spo0F complex. Destabilization of the RapH-Spo0F inter-
action following Spo0F dephosphorylation could enable RapH to
dissociate from non-phosphorylated Spo0F, freeing RapH to
participate in another round of Spo0F dephosphorylation.
RapH and a catalytically dead RapH mutant that cannot
dephosphorylate Spo0F inhibited phosphotransfer from KinA to
Spo0B (Figure 7 and unpublished data). Because receiver domains
readily adopt the phosphorylated conformation even in the absence
of phosphorylation [26,27,28], we hypothesize that RapH could be
bindingtoeitherphosphorylatedor non-phosphorylatedSpo0Fand
inhibiting the sporulation phosphorelay by sterically limiting kinase
and phosphotransferase access to the Spo0F active site. Consistent
with this hypothesis, RapA was previously shown to interact with
phosphorylated and non-phosphorylated Spo0F, albeit the interac-
tion with phosphorylated Spo0F appeared to be more stable than
the interaction with non-phosphorylated Spo0F [29]. We expect
that stericinhibition of Spo0Fphosphorylationwould have themost
significant biological effect when the concentration of Spo0F and
KinA are limiting and Rapproteins are in excess. In B. subtilis alone,
RapA, RapB, RapE, RapH, and RapJ all dephosphorylate Spo0F
and presumably block access to the Spo0F active site. Therefore, it
seems possible that the steric effects that Rap proteins have on
Spo0F phosphotransfer in addition to their phosphatase activity
may be physiologically relevant. Consistent with this hypothesis,
overexpressed catalyticallydeadRapH inhibitedphosphotransfer in
B. subtilis cells (Figure 6A).
The RapH-Spo0F structure revealed that the sidechain of
RapH Gln47 inserts into the Spo0F active site (Figure 5A).
Importantly, without exception, glutamine is conserved at this
position in Rap proteins known to dephosphorylate Spo0F
(Figure 4), and replacing RapH Gln47 with asparagine was
sufficient to completely eliminate phosphatase activity (Figures 5B).
We propose that RapH Gln47 orients water for direct in-line
hydrolytic attack on the Spo0F phosphoaspartate-54 phosphorous
atom (Figure 9D).
Consistent with our proposed model of RapH function and the
critical role that RapH Gln47 plays in dephosphorylating the
response regulator Spo0F, the CheZ and CheC/CheX/FliY
families of response regulator phosphatases insert a conserved
glutamine and asparagine, respectively, into their target response
regulator active sites where they orient water for nucleophilic
attack on the phosphoaspartate (reviewed in [7]). Aligning the
Spo0F molecule of RapHA-Spo0FA with the CheY molecules of
the CheZ-BeF3-CheY and CheX-BeF3-CheY structures shows
that the amide nitrogens in RapHA Gln47, CheZ Gln147, and
CheX Asn99 are positioned at nearly identical distances—6.1 A ˚,
5.7 A ˚, and 6.0 A ˚, respectively—from their corresponding receiver
domain active-site aspartate (Figure 9A and 9B). Consistent with
the hypothesis that RapHB-Spo0FB represents a conformation
adopted following RapH-mediated Spo0F dephosphorylation, the
amide nitrogen in RapHB Gln47 is located 1.1 A ˚ farther away
from the Spo0FB active-site aspartate than the RapHA Gln47
amide nitrogen is from the Spo0FA active-site aspartate.
Furthermore, aligning the Spo0F molecules of the RapHA-
Spo0FA and Spo0B-BeF3-Spo0F structures illustrates approxi-
Figure 5. In vitro phosphatase activity of RapH mutants targeting the RapH-Spo0F interface. (A) The RapHA 3-helix bundle (blue)
interaction with Spo0FA (brown surface). The phosphatase activity of RapH mutants corresponding to the residues depicted as green sticks was
tested. The main-chain nitrogen atom of RapHA residue Asp46 hydrogen bonds with the 2OH group of Spo0FA Tyr84. The surface of Spo0F Tyr84 is
colored red. (B) The ability of wild-type and mutant RapH mutants to dephosphorylate Spo0F,P was compared. Above each gel depicting the
phosphatase activity of a RapH mutant is a gel containing a wild-type RapH control reaction as well as a no RapH (Spo0F,P autohydrolysis) control
reaction. For the purpose of normalization across gels, identical samples (not shown) from the wild-type RapH control reactions were
electrophoresed alongside every RapH mutant reaction. The 5-min time point was ultimately used for across-gel normalization. (C) The RapHA TPR
domain (rainbow-colored cylinders) interaction with Spo0FA (brown surface). The phosphatase activity of RapH mutants corresponding to the
residues depicted as green sticks was determined. The surfaces of Spo0F Asp11 and Spo0F Tyr13 are colored red. (D) The ability of wild-type and
mutant RapH mutants to dephosphorylate Spo0F,P was compared as in (B). In order to measure the RapH-E137A phosphatase defect, 20 and
40 min time points were evaluated for RapH-E137A in lieu of 30 and 60 time points. Gels are representative of experiments repeated at least three
times for each RapH mutant.
doi:10.1371/journal.pbio.1000589.g005
Rap Phosphatase Structure and Function
PLoS Biology | www.plosbiology.org 10 February 2011 | Volume 9 | Issue 2 | e1000589mately where RapH Gln47 would position water for nucleophilic
attack on the phosphoaspartate phosphorous atom (Figure 9C;
[19]). More specifically, a water molecule hydrogen bonded to
RapH Gln47 Ne2 and lying in a position near those occupied by
Spo0B His30 Ce1 and Ne2 would be perfectly positioned for in-
line attack on the Spo0F phosphoaspartate phosphorous atom
(Figure 9C). We suspect that direct observation of the attacking
water molecule in the crystal structure will require crystallizing the
RapH-Spo0F-Mg
2+ complex in the presence of a non-hydrolyz-
able phosphoryl mimic such as beryllium fluoride or vanadate.
Consistent with our proposed mechanism of RapH-mediated
Spo0F dephosphorylation, there are no data suggesting that Spo0F
transfers phosphoryl groups to RapH resulting in the formation of
a phosphoenzyme intermediate. We detect no RapH phosphoen-
zyme intermediate in our in vitro assays, and it was previously
shown that RapB dephosphorylation of Spo0F was not inhibited
by the protein tyrosine phosphatase transition-state inhibitor
vanadate ([16]; and unpublished data).
While the catalytic mechanism of RapH-mediated Spo0F
dephosphorylation appears to be similar to the one employed by
CheZ and CheC/CheX/FliY family members, its overall
interaction with its target response regulator is different. Along
with the catalytic amide-containing sidechain, the CheZ and
CheC/CheX/FliY phosphatases insert an acidic amino acid
sidechain into the receiver domain active site where it forms a
salt bridge with the active site lysine equivalent to Spo0F Lys104
[30,31,32]. Insertion of the acidic residue into the receiver domain
active site is required for wild-type CheZ and CheC/CheX/FliY
family phosphatase activity. RapH inserts only an amide-
containing side chain into the target response regulator active
site, and the RapH-Spo0F structure shows that a salt bridge
between RapH and Spo0F Lys104 is not required for RapH
phosphatase activity.
Finally, while the explicit mechanistic basis of Spo0E family
phosphatase function is unknown, genetic and biochemical data
suggest that an acidic residue may be coordinating the water for
hydrolysis rather than an amide-containing side chain [33]. A
RapH mutant containing glutamate in place of the catalytic
residue, Gln47, could dephosphorylate Spo0F (Figure 5B). To-
gether, the structural and functional data presented here suggest
that glutamine or glutamate at the position equivalent to RapH
Gln47 is a requirement for Rap protein-mediated Spo0F
dephosphorylation.
The RapH-Spo0F Structure Supports T-loop-Y Coupling
In the T-loop-Y model of receiver domain allostery, the
conformation of the hydroxyl-containing switch residue is coupled
to the conformation of the b4-a4 loop, and the b4-a4 loop gates
conformational changes in the aromatic switch residue in b5 [34].
More specifically, when the b4-a4 loop is in an active site proximal
conformation, favored when the hydroxyl switch residue rotates
toward the active site, e.g. in response to phosphorylation, it causes
the internalization of the aromatic switch residue. Internalization
Figure 6. In vivo activity of RapH mutants targeting the RapH-
Spo0F interface. RapH activity was measured as a function of
PspoIIG::luc. (A) In vivo analysis of RapH proteins containing mutations
in the 3-helix bundle lying in the Spo0F interface as depicted in
Figure 5A. (B) In vivo analysis of RapH proteins containing mutations in
the TPR domain lying in the Spo0F interface as depicted in Figure 5C.
Each curve is representative of at least three independent experiments
performed in duplicate. (A and B) Wild-type and mutant rapH
overexpression was controlled by the IPTG-inducible promoter
Phyperspank. RLU, Relative Luminescence Units.
doi:10.1371/journal.pbio.1000589.g006
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protein-protein interactions that occur at the a4-b5-a5 surface of
receiver domains (reviewed in [35]). Interestingly, the existing data
support a T-loop-Y coupling model that is directional [34]. That
is, a b4-a4 loop oriented toward the active site dictates the
internalization of the aromatic switch residue side chain; however,
internalization of the aromatic switch residue does not restrict the
conformation of the b4-a4 loop.
Aligning Spo0FA with the structure of Spo0F bound to BeF3
and Spo0B showed that the Thr82 switch residues are in similar
positions pointing toward the active site in both models
(Figure 9C). However, His101 is in an internal position in the
RapHA-Spo0FA structure, while it is in an external position in the
Spo0B-BeF3-Spo0F structure (Figure 9C). In support of the T-
loop-Y coupling model, it appears that the internalization of
His101 in RapHA-Spo0FA, likely resulting from RapH-mediated
stabilization of the b4-a4 loop in the active-site proximal
conformation, is not observed in the Spo0F-BeF3-Spo0B structure.
Also consistent with this model, the Spo0FB His101 side chain is
free to adopt an external conformation, probably as a result of the
disordered Spo0FB b4-a4 loop.
Conclusion
The X-ray crystal structure of the response regulator phospha-
tase RapH in complex with one of its cellular targets, Spo0F,
combined with extensive biochemical and genetic analysis of
RapH mutants, reveals the mechanism of Rap-mediated phos-
phatase activity along with many of the structural requirements for
Rap phosphatase function. The approach presented here that
enabled us to assign Spo0F phosphatase function to RapJ based
only on its amino acid sequence could be used to predict the target
specificity of non-Spo0F phosphatase Rap proteins following the
determination of structures of representative complexes of the Rap
proteins bound to their targets. Furthermore, identifying the non-
Spo0F phosphatase Rap protein residues important for target
recognition will facilitate (1) the identification of Rap proteins
whose sequences suggest that they may not recognize previously
identified substrates, (2) the identification of new Rap protein
targets, and (3) rational engineering of de novo Rap protein target
specificity. The process of developing Rap proteins with
engineered target specificity will not only provide valuable insight
into the principles governing protein-protein interaction but will
also provide valuable reagents for studying bacterial signal
transduction. Finally, insight gleaned from our structure-function
analysis of RapH-Spo0F, along with additional studies of other
Rap proteins in complex with their response regulators, could be
used to develop new classes of drugs that disrupt the flow of
information along bacterial phosphotransfer signaling pathways by
mimicking the antagonistic effects of Rap proteins on response
regulators.
Materials and Methods
Protein Production for X-Ray Crystallography
RapH was PCR-amplified from B. subtilis strain 168 chromo-
somal DNA using Phusion High-Fidelity DNA Polymerase (NEB,
USA) and the oligonucleotide pair RapH-BamHI and RapH-NotI
(Table S3). The PCR product was cloned in the BamHI and NotI
restriction sites of pGEX4T1 (GE Healthcare) to yield pGEXH1.
GST-RapH was overexpressed in E. coli strain BL21 by first
growing the cells at 37uC in LB medium containing 100 mM
ampicillin to OD600=0.6 and then inducing expression with
0.1 mM isopropyl b-D thiogalactopyranoside (IPTG) for 16 h at
16uC. All subsequent purification steps were carried out at 4uC.
The cells were collected by centrifugation and lysed in buffer A
(20 mM Tris-HCl (pH 8.0), 250 mM NaCl, 50 mM KCl, 10 mM
MgCl2, 5 mM DTT, 10% glycerol) supplemented with 1 mM
Pepstatin, 1 mM Leupeptin, 20 mg/ml DNase, and 1 mM
phenylmethanesulfonyl fluoride (PMSF). The lysate supernatant
was applied to Glutathione Uniflow Resin (Clontech) equilibrated
in buffer A. The resin was then washed and resuspended in buffer
A, and thrombin was added at 0.3 mg/ml glutathione bed
volume. Overnight incubation at 4uC resulted in complete
cleavage of RapH from the GST affinity tag as determined by
SDS-PAGE. Following thrombin digestion, RapH (residues 1–
376) contained two heterologous N-terminal residues (Gly-Ser)
derived from the thrombin cleavage signal. RapH was eluted with
buffer A and diluted 3-fold with buffer B (20 mM Tris-HCl
(pH 8.0), 10 mM MgCl2, 5 mM DTT, and 10% glycerol), passed
through a 0.45 mm filter, and loaded onto an anion exchange
column (Source 15Q; GE Healthcare) equilibrated in buffer B
containing 50 mM KCl. RapH was then eluted in a 50–
1,000 mM KCl gradient of buffer B. Fractions containing RapH
were pooled, concentrated by ultrafiltration through a 30 kDa
filter, and further purified by gel filtration using a Superdex 200
(GE Healthcare) 16/70 column equilibrated in buffer C (20 mM
Tris-HCl (pH 8.0), 150 mM KCl, 5 mM MgCl2, and 5 mM
DTT). RapH was concentrated to 14 mg/ml and stored at
280uC.
Spo0F was PCR-amplified from B. subtilis strain 168 chromo-
somal DNA using Phusion High-Fidelity DNA Polymerase and the
oligonucleotide pair Spo0F-BamHI and Spo0F-NotI (Table S3).
The PCR product was cloned in the BamHI and NotI restriction
sites of pETDuet-1 (GE Healthcare) to yield pETDuetF1. The
Spo0F-D54E expression vector was obtained by site-directed
mutagenesis of pETDuetF1 using primers D54E_Spo0F_T and
D54E_Spo0F_B to give pETD54E (Table S3). Spo0F and Spo0F-
D54E were expressed in E. coli strain BL21(DE3) by first growing
the cells at 37uC in LB medium containing 100 mM ampicillin to
OD600=0.5 and then inducing expression with 1 mM IPTG for
16 h at 25uC. All subsequent purification steps were carried out at
4uC. Cells were collected by centrifugation and lysed in buffer D
(25 mM Tris-HCl (pH 8.0), 10 mM KCl, 40 mM MgCl2, and
5m M b-mercaptoethanol (b-ME)) supplemented with 1 mM
Pepstatin, 1 mM Leupeptin, 20 mg/ml DNase, and 1 mM PMSF.
The supernatant was applied to Glutathione Uniflow Resin
equilibrated in buffer D. Following a wash with three bed volumes
of buffer D, the resin was incubated with thrombin at 0.3 mg/ml
glutathione resin and incubated overnight at 4uC. SDS-PAGE
analysis confirmed that the GST tag was removed, and Spo0F was
eluted with buffer D. Following thrombin digestion, Spo0F
Figure 7. Rap proteins inhibit phosphotransfer from KinA to
Spo0F. RapH-Q47N does not catalyze Spo0F dephosphorylation (see
Figure 5B), but it sterically inhibits phosphotransfer from KinA to Spo0F.
RapH-Q47N,F58A contains the catalysis-eradicating Q47N active-site
mutation as well as the RapH-Spo0F interfacial mutation, F58A. RapH-
Q47N,F58A does not dephosphorylate Spo0F or inhibit phosphotransfer
from KinA to Spo0F. For the purpose of normalization across gels,
identical samples (not shown) from the no RapH control reaction were
electrophoresed alongside every RapH-containing reaction. The 60-min
time point was ultimately used for across-gel normalization. The gels
are representative of the results from three independent phospho-
transfer experiments.
doi:10.1371/journal.pbio.1000589.g007
Rap Phosphatase Structure and Function
PLoS Biology | www.plosbiology.org 12 February 2011 | Volume 9 | Issue 2 | e1000589Figure 8. Predicting and engineering Rap phosphatase activity. (A) RapJ dephosphorylates Spo0F,P. The gel is representative of
phosphatase assays repeated four times. (B) Size exclusion chromatography shows that RapJ (MWtheor 44.4 kDa) forms RapJ2 dimers (MWexper
92.0 kDa) in solution. The peak positions of gel filtration standards are indicated by vertical lines above the absorbance traces. (C) RapF-H50L
dephosphorylates Spo0F,P while wild-type RapF does not. The gels are representative of phosphatase assays repeated three times.
doi:10.1371/journal.pbio.1000589.g008
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(Gly-Ser) derived from the thrombin cleavage signal. The protein
was then further purified using anion exchange (Source 15Q) and
HiTrap Heparin HP (GE Healthcare) columns arranged in series
and equilibrated in buffer D. Spo0F eluted in the flow-through was
concentrated by ultrafiltration using a 10 kDa cutoff filter, and
subjected to gel filtration using a Superdex 200 16/70 column
equilibrated with buffer E (20 mM Tris-HCl (pH 8.0), 50 mM
KCl, and 5 mM MgCl2). Selenomethionyl Spo0F-D54E was
purified in an identical manner with the exception that buffer D
contained 120 mM MgCl2. Spo0F and selenomethionyl Spo0F-
D54E eluted exclusively as monomers were concentrated to
7.5 mg/ml and stored at 280uC.
Crystallization and Diffraction Data Collection
RapH-Spo0F crystals were produced by the vapor diffusion
method at 20uC using a 1:1 mixture of protein (7.5 mg/ml RapH
and 3.5 mg/ml Spo0F in 20 mM Tris-HCl (pH 8.0), 100 mM
KCl, 2.5 mM DTT, 5 mM MgCl2) and well solution (20% [w/v]
PEG 3350, 200 mM lithium sulphate, and 100 mM Bis-Tris
(pH 6.0)). RapH-Spo0F crystals were cryoprotected in mother
liquor solution containing 16.66 mM potassium phosphate buffer
(pH 6.0), 17.2 mM MgCl2, and 12.5% glycerol for 20 min.
Crystals containing RapH and selenomethionyl Spo0F(D54E)
were grown under similar conditions to the native RapH-Spo0F
crystals with the exception that the Bis-Tris was at pH 5.8.
Crystals containing the selenomethionyl derivatized Spo0F protein
were cryoprotected for 2–3 s in their mother liquor solutions
containing 10% glycerol, 3.5 mM MgCl2, and 1 mM DTT.
Single-wavelength anomolous dispersion (SAD) and native data on
nitrogen-cooled crystals were collected at NSLS beamline X29
and processed using the HKL software package [36].
Structure Determination and Refinement
The RapH-Spo0F crystal structure was determined by the SAD
method using crystals of native RapH bound to selenomethionyl
Spo0F(D54E) that are isomorphous to native RapH-Spo0F
crystals. PHENIX (AutoSol) was used to locate heavy atom
positions, calculate phases, and generate an initial model at 2.70 A ˚
resolution [37]. This model was then refined against 2.20 A ˚ native
data in PHENIX. The final model was generated through iterative
cycles of building in COOT [38] and refinement in PHENIX.
The RapH and Spo0F models were built de novo into the SAD-
phased map. The earliest rounds of refinement in PHENIX
employed simulated annealing as well as rigid body, individual
atomic coordinate, and individual B-factor refinement. The later
rounds of refinement in PHENIX employed individual atomic
coordinate and individual B-factor refinement, as well as a TLS
model whose initial parameters were guided by the TLS Motion
Determination (TLSMD) server [39]. During the final rounds of
refinement in PHENIX, the stereochemistry and ADP weights
were optimized, i.e. the weights yielding the lowest Rfree value
were used for refinement. Water molecules were added only after
the RapH and Spo0F models were complete. The vast majority of
the modeled water molecules are bound to RapHA or RapHB.
The water molecule B-factors are comparable to those of the
residues they are bound to. Insufficient electron density was
observed for the following residues and they were omitted from the
model: RapHA 1–3 and 69–76; RapHB 1–3, 27–45, 67–85, 292–
294; Spo0FA 1–3 and 120–124; and Spo0FB 1–3, 83–98, and 120–
124. Two molecules each of glycerol, sulfate, and Mg
2+ were built
into clear electron density during the final stages of refinement.
Ramachandran statistics were calculated in Molprobity [40].
Molecular graphics were produced with PyMOL [41].
Protein Production for Phosphatase and Phosphotransfer
Assays
RapH and RapF mutant expression vectors were generated by
site-directed mutagenesis of pGEXH1 and pGEXRapF using the
ChangeIT Mutagenesis Kit (USB) (Table S3). The expression
vectors contained only the desired mutations, as determined by
DNA sequencing. RapH, RapH mutants, RapF, and RapF-H50L
were overexpressed and purified as described for the RapH
protein used for crystallography with the exception that dialysis
was performed rather than gel filtration to exchange the SourceQ
column buffers for buffer C containing 10% glycerol.
rapJ was amplified from B. subtilis strain 168 genomic DNA
using Phusion High-Fidelity DNA Polymerase and the primer pair
RapJ-Fwd and RapJ-Rev (Table S3). The PCR product was
cloned into the SapI and XhoI sites of pTB146 using the In-Fusion
method (Clontech) to give pTB146J [42]. His-Sumo-RapJ was
overexpressed and purified using the RapH purification protocol
described above with the exceptions that buffer A had 10 mM b-
ME instead of 5 mM DTT, and instead of being applied to
glutathione resin the lysate supernatant was applied to Ni-NTA
agarose (Qiagen) equilibrated in buffer A. The Ni-NTA resin was
then washed in buffer A and resuspended in 65 mM Tris-HCl
(pH 8.0), 325 mM NaCl, 35 mM KCl, 7 mM MgCl2, 3.5 mM
DTT, 10% glycerol, and 0.2% NP-40. Sumo protease was then
added at 4 mg/ml Ni-NTA resin and incubated at 25uC for 2 h.
RapJ contained no heterologous residues following removal of the
N-terminal His-Sumo fusion. RapJ was then eluted, purified by gel
filtration (Superdex 200), and concentrated to 75 mg/ml. Aliquots
were stored at –80uC.
Figure 9. Structural comparison of response regulator phosphatase and phosphotransferase active sites, and a model of RapH-
Spo0F dephosphorylation chemistry. The Spo0FA molecule of RapHA-Spo0FA was aligned with the CheY molecule of CheZ-BeF3-CheY (PDB ID
1KMI) (panel A), the CheY molecule of CheX-BeF3-CheY (PDB ID 3HZH) (panel B), and the Spo0F molecule of Spo0B-BeF3-Spo0F (PDB ID 2FTK) (panel
C). Structural alignments were performed using DaliLite [45] and PyMol [41]. (Panel A) The amide nitrogens of RapHA Q47 and CheZ Q147 are similarly
positioned relative to their target receiver domain active-site aspartates. The RapHA Q47 and CheZ Q147 amide nitrogens are 5.9 A ˚ and 5.7 A ˚,
respectively, from the sites of phosphoryl group addition in their target receiver domains. (Panel B) The amide nitrogens of RapHA Q47 and CheX N99
are similarly positioned relative to their target receiver domain active-site aspartates. The RapHA Q47 and CheX N99 amide nitrogens are 5.9 A ˚ and
6.0 A ˚, respectively, from the sites of phosphoryl group addition in their target receiver domains. The water molecule that attacks the CheY
phosphoaspartate phosphorous atom in the CheX-BeF3-CheY structure is shown and reveals approximately where the attacking water may be
positioned during RapH mediated dephosphorylation of Spo0F. (C) The phosphoryl group mimic beryllium fluoride in the Spo0B-BeF3-Spo0F
structure shows where the phosphoryl group would lie in a RapH-Spo0F,P complex. The distances between the BeF3 fluorine atoms in the Spo0B-
BeF3-Spo0F structure and the atoms that are positioned to coordinate them in the structures of Spo0F-BeF3-Spo0B and RapHA-Spo0FA are depicted
as light blue dashed lines. The distances between the fluorine atoms and the coordinating Spo0FA atoms are in parentheses. The Spo0FA His101 side
chain is in an internal position in the RapHA complex, while the Spo0F His101 side chain in the Spo0B-BeF3 complex is not. This is consistent with the
active-site proximal and active-site distal conformations of their Spo0F b4-a4 loops (not shown), respectively. (D) A trigonal bipyramidal phosphoryl
group and attacking water were modeled into the RapH-Spo0F active site to generate a graphical depiction of the dephosphorylation transition
state. Amino acid positions reflect their conformations in RapHA-Spo0FA. Bonds are depicted as black dashed lines.
doi:10.1371/journal.pbio.1000589.g009
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and Spo0F-XhoI, digested with NdeI and XhoI, and cloned into
the pET21b (Novagen) NdeI and XhoI sites to give pET21bF
(Table S3). Spo0F containing a C-terminal fusion to hexahistidine
was then purified as previously described [21].
KinA was amplified from B. subtilis str. 168 genomic DNA using
the primer pair KinA-Fwd and KinA-Rev and cloned into the
NdeI and XhoI sites of pET15b using the In-Fusion method to
give pET15bK (Table S3). His-KinA was expressed in E. coli strain
BL21(DE3)plysS by first growing the cells at 37uC in LB medium
supplemented with 100 mg/ml ampicillin and chloramphenicol
17 mg/ml to OD600=0.4. His-KinA expression was then induced
for 16 h at 16uC with 0.5 mM IPTG. All subsequent protein
purification steps were carried out at 4uC. The cells were collected
by centrifugation, lysed in buffer F (25 mM Tris-HCl (pH 8.0),
450 mM KCl, 5 mM MgCl2, 1 mM DTT, 0.1 mM EDTA, and
10% glycerol) supplemented with 1 mM Pepstatin, 1 mM Leupep-
tin, 20 mg/ml DNase, and 1 mM PMSF. The supernatant was
applied to Ni-NTA agarose equilibrated in buffer F. The column
was then washed with buffer F containing 20 mM imidazole. To
remove the hexahistidine affinity tag, thrombin was added to
0.3 mg/ml Ni-NTA agarose bed volume in buffer F and incubated
overnight. KinA was eluted and passed over clean Ni-NTA resin
equilibrated in buffer F to remove any uncleaved His-KinA. KinA
was concentrated through a 30 kDa cutoff membrane and stored
at –80uC.
Spo0F Labeling
The Spo0F labeling reaction was performed at 25uC and
contained 206 mM Spo0F-His, 20 mM KinA, 0.25 mM[ c-
32P]
ATP, and phosphotransfer buffer (50 mM EPPS (pH 8.5), 20 mM
MgCl2, 0.1 mM EDTA, and 5% glycerol). After 1 h the reaction
was quenched with 7.5 mM cold ATP. Spo0F and Spo0F,P were
obtained at a ratio of 4:1 as determined by native-PAGE
electrophoresis followed by Coomassie staining and quantitation
with ImageJ [15,43].
In Vitro Phosphatase Assay
The Rap phosphatase assays were performed at 25uCa n d
initiated by adding radiolabeled Spo0F,P prepared as described
above to obtain a final reaction containing: 6.5 mM RapH, or
6.5 mM RapJ, or 26 mM RapF, and 6.0 mM radiolabeled
Spo0F,P, 24 mM Spo0F, 2.85 mM KinA, 13.25 mM Tris
pH (8.0), 50 mM EPPS (pH 8.5), 0.1 mM EDTA, 100 mM KCl,
23 mM MgCl2, 3 mM DTT, 11.6% glycerol 0.04 mM[ c-
32P]
ATP, and 1 mM ATP. Aliquots were removed at the indicated
times, mixed with an equal volume of 2X SDS loading buffer, and
stored on ice until they wereloaded onto 10%–20% polyacrylamide
Tris-Tricine-SDS gels. Following PhosphorImager analysis of the
gels, Spo0F,P levels were quantified using ImageQuant.
In Vitro Phosphotransfer Assay
To measure RapH inhibition of KinA phosphotransfer to
Spo0F, reactions were set up by preincubating 6.4 mM wild-type
or mutant RapH with 0.1 mM KinA and 0.04 mM[ c-
32P] ATP in
phosphotransfer buffer for 2 min at 25uC. Spo0F was then added
to each reaction. The final concentration of the reaction
components were: 6.5 mM wild-type or mutant RapH, 16.6 mM
Spo0F, 0.1 mM KinA, 5.4 mM Tris (pH 8.0), 50 mM EPPS
(pH 8.5), 0.4 mM Bis-Tris (pH 7.2), 0.1 mM EDTA, 41.7 mM
KCl, 21.4 mM MgCl2, 1.4 mM DTT, 7.9% glycerol, and
0.04 mM[ c-
32P] ATP. Aliquots were removed at the indicated
times. Spo0F,P levels were determined by Tris-Tricine-SDS
PAGE analysis and quantified as described above.
Construction of B. subtilis PspoIIG::luc Reporter Strains
The B. subtilis IS75 rapH-phrH null strain was constructed by first
replacing chromosomal rapH-phrH with a tetracycline resistance
cassette. The primers RapH1 and RapH2 were used to amplify a
1 kb DNA fragment upstream of rapH in the IS75 chromosome,
while primers RapH3 and RapH4 were used to amplify a 1 kb
DNA fragment downstream of phrH (Table S3). These PCR
products were then ligated to a tetracycline cassette to generate
upstream(rapH)-Tet-downstream (phrH). This product was then
PCR amplified using the primers RapH1 and RapH4, purified,
and transformed into B. subtilis IS75. Double crossover between
the chromosome regions homologous to the upstream(rapH) and
downstream(phrH) portions of (rapH)-Tet-downstream(phrH) re-
places the entire rapH-phrH operon with tetracyline. The DrapH-
phrH::tet strain was named BD5031. The rapH-phrH deletion in
BD5031 was confirmed by DNA sequencing using primers
RapH1seq, RapH2seq, RapHseq5R, Tet_seq1, and Tet_seq2,
as well as by Western blotting using anti-RapH rabbit antisera
(Table S3 and Figure S4). Chromosomal DNA from BD5031 was
isolated and transformed into strain PP533, which contains
PspoIIG::luc inserted by Campbell recombination at the native
spoIIG promoter, to yield strain BD5035 DrapH-phrH::tet,P spoII-
G::luc. To generate site-directed mutations in the BD5035 rapH
gene, rapH was amplified from wild-type B. subtilis by PCR and
inserted into the SalI and SphI sites in pDR111 (a kind gift from
D. Rudner, Harvard Medical School). The resulting plasmid,
pDRH1, was then mutagenized using a common forward primer
(FWD AMP) in combination with the appropriate mutagenic
primer using the ChangeIT Mutagenesis Kit (USB) (Table S3).
DNA sequencing confirmed that the rapH plasmids were free of
mutations other than those introduced by site-directed mutagen-
esis. pDRH1-derived plasmids were then transformed into
BD5035 DrapH-phrH::tet,P spoIIG::luc, which by double-crossover
recombination at the amyE locus yields strains expressing the entire
wild-type or mutant rapH locus under the control of the IPTG-
inducible hyperspank promoter.
Luciferase Bioassays
Luciferase from Photinus pyralis was employed as a reporter
because it is highly unstable in B. subtilis. We detected less than 50%
luciferase activity after less than 8 min following the addition of the
protein translationinhibitorpuromycin togrowingbioluminescence
reporter strains (unpublished data). Thus, the response dynamics of
the assay are such that we are measuring the rate of gene
transcription in near real-time rather than the prolonged accumu-
lation of a highly stable reporter such as b-galactosidase. The
reporter strains were grown in LB medium to OD600<2,
centrifuged, and resuspended in fresh Sporulation Medium
(DSM) [44] to OD600=2. The cultures were then diluted 20-fold
in fresh DSM supplemented with 0.25 mM IPTG, and 200 ml were
dispensed per well in duplicate in a 96-well black plate (Corning).
10 ml of luciferin was added to each well at a final concentration of
4.7 mM. The cultures were then incubated at 37uC under agitation
in a PerkinElmer Envision 2104 Multilabel Reader. The plate lids
were heated to 38uC to avoid condensation. Relative Luminescence
Unit (RLU) and OD600 were measured at 1.5 min intervals.
Antibody Production and Immunoblotting
Anti-RapH antiserum was recovered from rabbits injected with
purified RapH protein (Lampire Biological Laboratories). B.
subtilis whole-cell lysates were electrophoresed on SDS-PAGE gels
and blotted to PVDF membrane. Immunostaining was performed
using anti-RapH rabbit antisera followed by anti-rabbit IgG HRP-
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nescence (Pharmacia).
Accession Numbers
Atomic coordinates and structure factors for RapH-Spo0F have
been deposited in the Protein Data Bank under accession code
3Q15.
Supporting Information
Figure S1 The (RapHB-Spo0FB)2 heterotetramer. (A) RapHB
(blue), Spo0FB (brown), RapHB9 (green), and Spo0FB9 (magenta).
RapHB residues 27–45 and 292–294 are disordered and represented
by blue and green dashed lines in RapHB and RapHB9, respectively.
Spo0FBresidues 83–98aredisordered andarerepresented bybrown
and magenta dashed lines, respectively. (B) To obtain this view of
RapHB, the structure illustrated in panel A was rotated 90u in the
direction indicated by the arrow. The RapHB N-terminal 3-helix
bundle (light blue) is connected to the C-terminal TPR domain by a
flexible linker (black dashed lines) and a short helix (black cylinder).
TheRapHBdisordered residues27–45and292–294arerepresented
by light blue and grey dashed lines, respectively.
Found at: doi:10.1371/journal.pbio.1000589.s001 (1.65 MB TIF)
Figure S2 RapHA and RapHB structural alignment. Structural
alignment of RapHA (blue) and RapHB (dark pink) illustrates their
conformational differences. A portion of the RapH 3-helix bundle
(residues 27–45) is disordered in RapHB but ordered in RapHA,
and residues in and adjacent to this region make regulatory
contacts with Spo0F. The N-terminal region of RapHA, extending
from the 3-helix bundle to TPR1 helix A, is rotated slightly away
from the C-terminal TPR domain. The most prominent
displacements occur near the C-terminal ends of helices a1 and
a3, helix a4, the loop connecting a4 to the N-terminus of TPR1
helix A (a5), and in the residues near the N-terminus of TPR1
helix A. Structural alignments were performed with Dali-Lite [45].
Found at: doi:10.1371/journal.pbio.1000589.s002 (1.55 MB TIF)
Figure S3 RapH-Spo0F interface. (Bottom panel) Expanded
view highlighting the RapH-Spo0F interaction contained within
the area enclosed by the black rectangle in the top panel. Spo0F
residues 11–18, 21–22, 25, 34–38, 56–60, 83, 84, 104–106, 108,
109, and 112 (magenta) are buried in the RapH (blue) interface.
The Spo0F secondary structure elements containing residues
buried in the RapH interface are labeled with magenta type.
Spo0F residues not buried in the RapH interface are colored
yellow. To help illustrate the fact that the RapH-Spo0F interface
surrounds the Spo0F active site, the side chain of the Spo0F active-
site aspartate-54 is depicted (green sticks).
Found at: doi:10.1371/journal.pbio.1000589.s003 (2.48 MB TIF)
Figure S4 Western blot analysis of RapH expression. B. subtilis
whole-cell extracts were analyzed by Western blotting to
determine the expression level of wild-type and mutant RapH
proteins. Western blotting also confirmed the absence of RapH in
strain BD5035 (DrapH-phrH::tet,P spoIIG::luc).
Found at: doi:10.1371/journal.pbio.1000589.s004 (0.47 MB TIF)
Table S1 Phasing and refinement statistics. Data for the highest
resolution shell are given in parentheses. Rsym~ShSijIi h ðÞ {
SIh ðÞ TjShSiIi h ðÞ , where Ii(h) is the i
th measurement of h and
,I(h). is the mean of all measurements of I(h) for reflection h.
Rcryst~SjjFoj{jFcjj=SjFoj, calculated with a working set of
reflections. Rfree is Rcryst calculated with only the test set (6.2%) of
reflections. The protein molecule average B-factors were calculat-
ed using values that included both B-residual and B-TLS. FOM,
figure of merit.
Found at: doi:10.1371/journal.pbio.1000589.s005 (0.07 MB
DOC)
Table S2 Rap protein amino acid identity in highly conserved
positions lying in the RapH-Spo0F interface. RapA, RapB, RapE,
RapF, RapH, RapJ, and Rap60 sequences refer to B. subtilis Rap
proteins. BXA0205 and BA3790 sequences refer to B. anthracis
Rap proteins. Sequences were aligned in Geneious Pro and
analyzed using the ConSurf server [46]. Rap60 is included in this
table because previous in vivo studies suggest that Rap60 is a
phosphatase, and our alignments show that the Rap60 amino acid
sequence conserves all of the residues found to be functionally
important for Spo0F dephosphorylation [47]. RapF residue His50
disables its phosphatase activity (H shown in bold).
Found at: doi:10.1371/journal.pbio.1000589.s006 (0.04 MB
DOC)
Table S3 Oligonucleotides.
Found at: doi:10.1371/journal.pbio.1000589.s007 (0.07 MB
DOC)
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